Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Open Access
- 5 June 2014
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 123 (23), 3664-3671
- https://doi.org/10.1182/blood-2014-01-552984
Abstract
Key Points: The DRI successfully stratified patients in a very large allogeneic transplantation registry cohort. The DRI was refined by using this cohort to build a more inclusive and conditioning intensity–independent index.Keywords
This publication has 17 references indexed in Scilit:
- Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant Research StudyTransplantation and Cellular Therapy, 2012
- Philadelphia Chromosome Is Not an Adverse Prognostic Factor in Acute Lymphoblastic Leukemia After Myeloablative Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2011
- Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow TransplantationBlood, 2010
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationThe New England Journal of Medicine, 2010
- Multicenter validation study of a transplantation-specific cytogenetics grouping scheme for patients with myelodysplastic syndromesBone Marrow Transplantation, 2009
- The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant ResearchBone Marrow Transplantation, 2008
- Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions to Predict SurvivalTransplantation and Cellular Therapy, 2008
- Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic TransplantationTransplantation and Cellular Therapy, 2007
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- Regression modelling strategies for improved prognostic predictionStatistics in Medicine, 1984